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Abstract
Forkhead box O (FoxO) transcription factors (TFs) are key drivers of complex transcriptional programmes that determine
animal lifespan. FoxOs regulate a number of other TFs, but how these TFs in turn might mediate the anti-ageing
programmes orchestrated by FoxOs in vivo is unclear. Here, we identify an E-twenty six (ETS)-family transcriptional repressor,
Anterior open (Aop), as regulated by the single Drosophila melanogaster FoxO (dFOXO) in the adult gut. AOP, the functional
orthologue of the human Etv6/Tel protein, binds numerous genomic sites also occupied by dFOXO and counteracts the
activity of an ETS activator, Pointed (Pnt), to prevent the lifespan-shortening effects of co-activation of dFOXO and PNT. This
detrimental synergistic effect of dFOXO and PNT appears to stem from a mis-regulation of lipid metabolism. At the same
time, AOP activity in another fly organ, the fat body, has further beneficial roles, regulating genes in common with dfoxo,
such as the secreted, non-sensory, odorant binding protein (Obp99b), and robustly extending lifespan. Our study reveals a
complex interplay between evolutionarily conserved ETS factors and dFOXO, the functional significance of which may
extend well beyond animal lifespan.
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Introduction
Forkhead Box O (FoxO) transcription factors (TFs) play a key,
evolutionarily conserved role in ageing. Drosophila melanogaster
has a single FoxO orthologue (dfoxo) and increasing its activity in
certain tissues is sufficient to extend fly lifespan [1–4] Furthermore,
both dfoxo and the Caenorhabditis elegans othologue, daf-16, are
strictly required for lifespan extension upon reduction in insulin/
IGF-like signalling (IIS) [5,6]. This evolutionary conservation
appears to extend all the way to yeast on one side, where forkhead-
like factors can extend lifespan [7], and to humans on the other,
where certain variants of the FoxO3A locus are robustly correlated
with longevity [8–12].
FoxOs control a plethora of traits at both organismal and
cellular levels, including control of cell cycle, cell death, growth
and metabolism. In all cases, FoxOs can be viewed as acting to
preserve homeostasis [13]. Indeed, numerous processes are
remodelled by activation of FoxOs, through regulation of a large
number of direct and indirect targets, all acting in concert to
preserve homeostasis in old age and extend animal lifespan [14–
19].
Several studies have examined the targets of FoxOs. A striking
finding of these studies is that FoxOs control a range of other
cellular regulators. These include secreted endocrine factors,
components of intracellular signalling pathways and several TFs
[14,16–20]. Transcriptional feedback within the signalling path-
way plays a role [21], but in most cases the functions of these other
regulators remain unknown, both in isolated cells and, more
importantly, in vivo.
The putative roles of TFs regulated by FoxOs are particularly
intriguing. Numerous studies have shown that FoxOs interact with
a number of unrelated TFs, in a number of ways, with important
consequences for the output of both interacting partners [13,22].
These TFs include Myc, p53, Smads, ß-catenin, and numerous
nuclear hormone receptors [22–27]. Hence, there is a potential for
the TFs regulated by FoxO to profoundly alter FoxO’s functional
output through interactions with FoxO itself. However, it remains
unclear what the role of these interactions is in the whole animal,
in vivo and, specifically, what is their role in lifespan?
In this study we set out to elucidate the role played in lifespan by
a TF directly regulated by dFOXO. We identify an E-twenty six
(ETS) - family transcriptional repressor, Anterior open (Aop), as
regulated by dFOXO in the adult Drosophila gut. Aop is the
functional orthologue of the human Etv6 gene and, in Drosophila,
it is known to counteract the activity of an ETS activator, Pointed
(Pnt). We show that Aop acts to prevent the detrimental effects of
co-activation of dFOXO and PNT in adult Drosophila gut, and we
present evidence that this interaction is mediated by binding to the
same genomic locations as dFOXO. AOP activation on its own in
the adult fat body can also robustly extend lifespan. Our study
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reveals a complex interplay between evolutionarily conserved
ETS-family TFs and dFOXO in longevity. The significance of this
interplay may extend to other physiological processes.
Results
dFOXO regulates distinct genes but similar functions in
the adult gut and fat body
dFOXO, like its mammalian orthologues, controls gene
expression in a tissue-specific manner [19,28–30]. Hence, to
investigate the functional interplay between dFOXO and one of its
target TFs, we turned our attention to a tissue-specific, adult-
inducible, lifespan-relevant system. Over-expression of dfoxo using
the RU486-inducible, S1106 Geneswitch driver [31], robustly
extends lifespan [1,4,32–34]. S1106 restricts dfoxo induction to
two specific adult fly organs: the midgut and abdominal fat body
(subsequently referred to as gut and fat body; Figure S1A) [31],
the latter functionally equivalent to mammalian white adipose
tissue and liver. Both have an evolutionarily conserved role in
aging [35,36], and it is currently unclear whether activation of
dfoxo in either organ alone is sufficient to extend lifespan. For
these reasons, we chose to identify the TFs regulated by dFOXO
in both of these organs.
We micro-dissected mid-guts or carcass-associated thoracic/
abdominal fat body of S1106.dfoxo females (+/2 RU486) and
determined their mRNA profiles using Affymetrix gene expression
arrays (ArrayExpress accession number: E-MTAB-1020). In each
case, we controlled for the changes associated with induction of the
driver alone (S1106 +/2 RU486). 447 genes were differentially
expressed in the gut (p value cut-off of 0.00285 corresponding to
FDR of 5%, Figure 1A). We detected fewer significant changes in
the fat body, 87 differentially regulated genes (p value cut-off
0.0022, FDR 20%, Figure 1A), most-likely due to the difficulty of
dissecting this loosely-associated tissue. The full list of genes
regulated by dFOXO, as well as all other lists mentioned in the
paper, are given in Dataset S1. The list included some well-
known targets of dFOXO, such as initiation factor 4E binding
protein (4ebp) [37,38] and the Drosophila insulin receptor (dInR)
[37], both activated in the gut, and the insulin-regulated kinase Akt
[17,39], induced in both the gut and fat body.
The overlap between genes regulated in the same direction in
gut and fat body was significant (p = 0.002 for up-regulated,
p,10215 for down-regulated genes), but by no means complete
(Figure 1A), indicating that dFOXO regulates both related and
unrelated sets of genes in the two tissues. This did not appear to be
caused by weaker signal obtained from the fat body, since changes
unique to the fat body were also detected (e.g. Obp99b; see later).
To further explore this, we examined the functions regulated by
dFOXO in the two tissues using Catmap, an approach that can
detect co-ordinated, subtle changes over many genes, rather than
depending on an arbitrarily chosen, differential expression p-value
cut-off [40]. Although some differences occurred, the biological
process Gene Ontology (GO) categories differentially expressed in
the two tissues were similar (Figure 1B), indicating that dFOXO
regulates similar functions in the gut and in the fat body.
Notably, dFOXO strongly repressed respiratory electron
transport chain components in both the gut and fat body
(p = 4610225 and p= 1610221, respectively) and, in particular,
components of complex I, which transfers electrons from NADH
to ubiquinone (p = 2610219 and p= 2610217). Indeed, part of the
effect of dFOXO on lifespan could be mediated by its repression of
the components of complex I, because reducing the electron flow
through this complex, by bypassing it, can extend fly lifespan
[41,42].
5 TFs are directly regulated by dFOXO in the adult gut
We identified a total of 16 TFs regulated by induction of dfoxo
in either the gut or the fat body, including p53 and the nuclear
hormone receptor HR96 (see Dataset S1 for the full list). To
further narrow down the set of interesting candidates, we isolated
the TFs encoded by genes directly bound and regulated by
dFOXO, thus identifying the immediate second tier of regulators.
We determined the genomic regions bound by dFOXO using a
GFP-dFOXO fusion protein that is functional in lifespan-
extension [33]. We prepared chromatin from RU486-fed
S1106.GFP-dfoxo female flies and pulled down the DNA
associated with the fusion protein, and hence restricted to gut
and fat body, using an anti-GFP antibody. As a control, we
performed chromatin immunoprecipitation (ChIP) using the same
antibody on chromatin prepared from females over-expressing
dfoxo alone (S1106.dfoxo + RU486).
To confirm that we were detecting tissue-restricted binding, we
compared the GFP-dFOXO bound sites with those that we
previously identified in whole adults or S2 cells [17]. The dInR
locus is transcribed from three promoters under tight spatio-
temporal control [43]. In whole flies, dFOXO is detected as bound
in the coding region of the gene and is absent from the P1 or P3
regions [17] (Figure 2A). The functional significance of this
binding in the 39 region in Drosophila is unclear but the
mammalian FoxO proteins are able to act at great distances
[20]. On the other hand, in serum-starved S2 cells dFOXO is
bound to the P1 promoter but not the coding or P3 regions [17]
(Figure 2A). In contrast, GFP-dFOXO expressed in the adult gut
and fat body was bound to the P3 promoter of dInR (Figure 2A),
revealing a different pattern of binding in these tissues.
We hybridised three biological repeats of the experimental and
control ChIP samples to tiling arrays. We identified ,1400
genomic regions bound by GFP-dFOXO in the gut and/or the fat
body (ArrayExpress accession number: E-MTAB-1021; for
examples of peaks identified see Figure 2B; for a list of all bound
locations see Dataset S1), with highly reproducible ChIP-chip
signal across the three biological replicates (Figure S1B). The
Author Summary
Despite the apparent complexity of ageing, animal lifespan
can be extended. Activity of Forkhead Box O (FoxO)
transcription factors can prolong survival of organisms
ranging from the budding yeast to the fruit fly, and FoxO
gene variants are linked to human longevity. FoxOs extend
lifespan by driving complex, widespread changes in gene
expression. Their primary targets include a second tier of
transcriptional regulators, but it remains unclear how these
secondary regulators are involved in the anti-ageing
programmes orchestrated by FoxOs in vivo. To elucidate
the role of this second tier, we identify a transcription
factor called Anterior open (Aop) as directly regulated by
the single Drosophila melanogaster FoxO protein (dFOXO)
in the adult fly gut. Under certain circumstances, such as
co-activation of the Pointed (PNT) transcription factor,
dFOXO can be detrimental to lifespan. The role of Aop is to
protect from this negative synergistic effect. Additionally,
activation of AOP in the fly adipose tissue can robustly
extend lifespan. Our study reveals a complex interplay
between two evolutionarily conserved transcriptional
regulators and dFOXO in lifespan. This significance of this
interplay may extend to other physiological processes
where these transcription factors play important roles.
dFOXO-AOP-PNT Transcriptional Circuit in Lifespan
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regions occupied by dFOXO in the gut and fat body were
different from those previously identified in whole flies (Figure
S1C), further confirming that we were detecting tissue-restricted
binding. They were predominantly located in the 59 end of genes
(Figure S1D), indicating promoter-proximal binding, in contrast
to enhancer binding observed with mammalian FoxO3 [20]. The
regions bound by dFOXO were enriched for forkhead-like
binding motifs (Figure S1E), confirming conservation of in vivo
binding-sequence preference.
Finally, we identified the genes that are likely to be directly
regulated by dFOXO based on their transcriptional responsive-
ness to induction of dfoxo and proximity (,1 kb) to a GFP-
dFOXO bound site (Figure 1A). Genes up-regulated in the gut
were specifically enriched for the GFP-dFOXO bound genes
(p = 561029). This is consistent with the predominant function of
dFOXO as a transcriptional activator, conserved in its worm and
mammalian orthologues [16,19,20]. We also observed GFP-
dFOXO binding in the vicinity of the genes regulated by dfoxo
in the fat body (Figure 1A), but this overlap was not significant.
Note that numerous GFP-dFOXO-bound sites could not be
associated with specific transcriptional events. This has been
observed previously for FoxO factors in flies and other organisms
[16,17,19,20,28], and it is currently unclear whether this is due to
technical limitations in associating expression changes to binding
events, whether FoxOs detected on these sites are poised for
activation under a different set of conditions, or whether some of
these sites are not functional.
The set of direct dFOXO targets included five sequence-specific
TFs: clockwork orange (cwo), mothers against dpp (Mad), bunched
(bun), anterior open (Aop) and CG12054 (summarised in
Figure 2C). All of these were activated by dFOXO in the gut
(Figure S1F, for Aop see also Figure 3). dFOXO also bound its
Figure 1. dFOXO targets in the adult gut and fat body. A Proportional Venn diagram showing the sets of genes that were differentially
regulated by dfoxo induction in the gut or the fat body. The number of genes that were bound by GFP-dFOXO within each differentially expressed-
gene set are given in black. p values for significant set overlaps are indicated. B Biological process GO categories differentially regulated (p,10210) in
the fat body or gut upon induction of dfoxo as determined by Catmap analysis. Any redundant categories (overlap by more than 75%) were removed,
retaining the most specific category. The full list is given in Dataset S1. The intensity of red shows the log10-transformed p-value associated with
differential regulation for each category.
doi:10.1371/journal.pgen.1004619.g001
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own locus, and inducing the transgenic and intron-less dfoxo in
S1106.dfoxo females resulted in an increase in unspliced dfoxo
(Figure S1G), indicating that dFOXO self-activates (Figure 2C).
dFOXO induces an ETS transcriptional repressor in the
adult gut
Among the TFs discovered as directly activated by dFOXO in
the gut, we were especially interested in Aop (a.k.a. Yan). This
ETS-family transcriptional repressor has a clear human ortholo-
gue in the Etv6 (a.k.a. Tel) gene [44]. Aop and Etv6 display clear
conservation of function, with Aop involved in tracheal sprouting
in flies while Etv6 is involved in the equivalent process of
endothelial sprouting in mammals [45]. Interestingly, mammalian
FoxOs and Etv6 act in similar physiological processes: both are
tumour suppressors required for maintenance of adult haemato-
poietic stem cells [30,46]; indicating that the previously-unchar-
acterised, functional interplay between the two factors may be
evolutionarily conserved. Importantly, Drosophila presents a
unique opportunity to examine the physiological functions of
Aop/Etv6, because there is no known orthologue in yeast or
worm.
ChIP-chip revealed that GFP-dFOXO bound in the promoter-
proximal, 59 end of Aop, specifically in the 1st exon and 1st intron
(Figure 3A). The binding to the 1st exon in the gut/fat body was
confirmed with qPCR (Figure 3B). Similarly to dInR, we
previously observed dFOXO bound to the coding region (39
end) of this gene in whole flies (see [17] and Figure 3A and B).
The functional significance of this 39-end binding is unclear [17].
Induction of dfoxo in the gut and the fat body resulted in
significant induction of Aop transcript only in the gut (p = 0.002,
Figure 3C). To confirm the statistical significance of this tissue-
restricted effect of dfoxo, we analysed the Aop expression data with
a mixed-effects linear model and found a significant difference in
the way the two tissues respond to RU486 (p,0.05). To confirm
that these effects were cell autonomous, we induced dfoxo solely in
the gut using an RU486-inducible, gut-specific driver, TIGS [31].
Feeding RU486 to TIGS.dfoxo females also resulted in induction
of Aop transcript in the gut (Figure 3C). Hence, dFOXO induces
Aop transcription in the gut, most likely through direct binding to
the Aop promoter in gut cells.
Aop prevents the detrimental co-activation of dfoxo and
Pointed
To understand the relationship between dfoxo and its target TF,
Aop, we next examined the physiological role played by Aop in the
context of tissue-restricted dfoxo induction and lifespan. Since Aop
Figure 2. dFOXO binding sites in adult gut and fat body. A Enrichment of the P3 promoter sequences of the dInR locus in the chromatin
samples prepared from RU486-fed S1106.GFP-dfoxo, RU486-fed S1106.dfoxo (mock for the anti-GFP IP), wild-type 7-day old females or 2-h serum-
starved S2 cells, after IP with either anti-GFP antibody or anti-dFOXO antibody, as indicated. Enrichment is expressed relative to U6, as means 6 SEM
of three biological replicates of chromatin, except for S2 cells where three IPs were performed from the same chromatin sample. ANOVA on log-
transformed data detected significant differences (p,1023), and enrichment in S1106.GFP-dfoxo, after IP with anti-GFP antibody, was greater than all
others (t-test, p,1023). B ChIP-chip traces, showing the enrichment (log2-transformed) of the GFP-dFOXO-immunoprecipitated DNA over total
chromatin, are averages of three biological repeats after subtraction of the mock and are shown over a region of chromosome 3R. Red denotes the
enrichment associated with peak regions. C Summary of the regulatory relationships between dFOXO and the five TFs it directly induces in the adult
gut. Arrows indicate transcriptional activation.
doi:10.1371/journal.pgen.1004619.g002
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is an essential gene [47,48], we chose to knock it down in the adult
gut and fat body using a short-hairpin RNAi construct with no
predicted off-targets [49]. Driving this construct with a ubiquitous,
constitutive driver (daughtelessGAL4) resulted in the expected
embryonic lethality. Inducing this construct in the adult gut and
fat body, using the S1106 driver, reduced the levels of Aop mRNA
by ,70% (p= 0.04, Figure S2A) but had no major effect on
lifespan (Figure 4A), revealing that, in a wild-type fly, Aop in
these tissues is not limiting for survival.
To test if Aop is required for the dfoxo-induced longevity, we
simultaneously expressed dfoxo and knocked-down Aop. Surpris-
ingly, while dfoxo alone extended lifespan, this combined
treatment was detrimental to the fly (Figure 4A), indicating that
Aop is required to prevent some toxic effect of dfoxo activation
[39]. To determine the statistical significance of this synergistic
effect, we used Cox Proportional Hazards (CPH) analysis [50].
This type of survival analysis can determine the significance of
individual covariates as well as their interaction. We used
‘‘genotype’’ and ‘‘RU486’’ as individual covariates and found
that the response to RU486 was significantly different in S1106.
dfoxo AopRNAi genotype from the response in either S1106.dfoxo
or S1106. Aop
RNAi genotypes (interaction of ‘‘genotype’’ and
‘‘RU486’’, p = 5610215 and p= 161027, respectively). This
confirmed the synthetic interaction between the loss of Aop and
induction of dfoxo. Importantly, expressing a control RNAi
construct targeting GFP with S1106 driver did not prevent dfoxo
from extending lifespan (Figure S2B).
We next examined the mechanism underlying this toxic effect of
inducing dfoxo in the absence of Aop. Aop’s activity is known to
counteract that of Pointed (Pnt), an ETS-family transcriptional
activator [51,52]. These two TFs regulate the same genes through
binding to the same regulatory elements but with opposing
outcomes [51–53]. Hence, the synthetic toxicity of Aop loss- and
dfoxo gain-of-function indicated that co-activation of Pnt and
dfoxo could be highly detrimental. To test this, we induced the
constitutively active form of Pnt (PntP1) [51] in the adult gut and
fat body. This resulted in a marginal negative effect on lifespan
(p = 0.06) and, similarly to the phenotype of Aop loss and dfoxo
gain, the co-induction of dfoxo and PntP1 was highly detrimental
(Figure 4B).
Figure 3. dFOXO regulates expression of Aop in the adult gut. A Schematic of the Aop locus with black boxes representing exons, red boxes –
regions detected as bound by GFP-dFOXO in the ChIP-chip experiment on induced S1106.GFP-dfoxo females (dFOXO gut/fat body), yellow box -
region detected as bound by dFOXO in wild-type females (dFOXO whole fly, data obtained from reference [17]), and black bars – position of
amplicons used for qPCR in B. B The enrichment of 59 or 39 end of the Aop locus, relative to U6, after anti-GFP IP of chromatin from RU486-induced
S1106.dfoxo females (mock), anti-GFP IP of chromatin from RU486-induced S1106.GFP-dfoxo females (gut/fat body) or anti-dFOXO IP of wild-type
female chromatin (whole fly). Means 6 SEM of three biological repeats are shown, with enrichment in the mock control set to one. ANOVA on log-
transformed data detected significant differences (p = 0.03 per region) and the enrichment of the 59 region was different in gut/fat body from the
mock (one-tailed t-test, p = 661023), while the 39 region was enriched in the whole fly (one-tailed t-test, p = 561023). C Aop mRNA was quantified
relative to Act by qPCR in guts or fat bodies of S1106.dfoxo, or TIGS.dfoxo flies induced or not with RU486. Boxplots show log-10 derived relative
expression with - RU486 values set to zero. Data for S1106.dfoxo females were analysed with a mixed-effects linear model with dissection batch as a
random effect. The effects of RU486, tissue and their interaction was significant (p,0.05) and RU486 caused significant up-regulation of Aop in the
gut (one-tailed t-test, n = 3–4, p = 261023) but not the fat body (one-tailed t-test, n = 4, p.0.05). Significant changes were observed in TIGS.dfoxo
guts (t-test, n.3, p = 0.02).
doi:10.1371/journal.pgen.1004619.g003
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It was possible that dFOXO induced the transcription of Aop in
order to avert co-activation of PNT and the resulting detrimental
synergistic effect. Indeed, the detrimental effect of combined
dFOXO and PNT activity was completely rescued by additional
activation of AOP, achieved by expression of a constitutively
active form of Aop [48], called AopACT, in addition to dfoxo and
PntP1 (Figure 4B). The significance of this effect was confirmed
by CPH analysis, which showed that the response to RU486 in
S1106.Pnt
P1 genotype was significantly different from that in
S1106.Pnt
P1 dfoxo genotype (p,10215), but not from the
response observed in S1106.Pnt
P1 dfoxo AopACT (p = 0.5).
Importantly, induction of AopACT did not interfere with the
induction of dfoxo or PntP1 in the S1106.Pnt
P1 dfoxo AopACT
females compared to the S1106.Pnt
P1 dfoxo females (Figure
S2C).
dFOXO regulates Aop transcription specifically in the gut
(Figure 3C). For this reason we next examined whether the
genetic interactions we observed between dfoxo and Aop/Pnt
could be recapitulated with the gut-specific TIGS driver. This
driver has been successfully used by others to determine the
Figure 4. Aop prevents the detrimental effects of dfoxo and Pnt co-activation. A Survival of female flies expressing dfoxo, AopRNAi or both
under the control of S1106 in the presence or absence or RU486. Log-rank test revealed significant effect of RU486 for S1106.dfoxo (p,10
24; total
dead/censored:2 RU486 145/0, + RU486 139/6; median/maximum lifespan:2 RU486: 77/87, + RU486 80/90) and S1106.dfoxo AopRNAi (p,1024; total
dead/censored: 2 RU486 145/2, + RU486 155/2; median/maximum lifespan: 2 RU486: 74/90, + RU486 65/79) but not S1106.AopRNAi (p = 0.5; total
dead/censored: 2 RU486 142/0, + RU486 147/4; median/maximum lifespan: 2 RU486: 72/86, + RU486 74/87). CHP analysis showed that the response
to RU486 in S1106.dfoxo Aop
RNAi was significantly different from the response in S1106.dfoxo (p,5610
215) and S1106.Aop
RNAi (p,1027) females. B
Survival of female flies expressing dfoxo, PntP1 and AopACT under the control of S1106 in the presence or absence or RU486. Log-rank test revealed
significant effect of RU486 for S1106.Pnt
P1 dfoxo (p,1024; total dead/censored: 2 RU486 138/6, + RU486 145/2; median/maximum lifespan: 2
RU486: 77/90, + RU486 63/83) but not S1106.PntP1 (p = 0.06; total dead/censored: 2 RU486 147/0, + RU486 143/2; median/maximum lifespan: 2
RU486: 84/92, + RU486 79/90) or S1106.PntP1 dfoxo AopACT (p = 0.1; total dead/censored: 2 RU486 147/3, + RU486 142/3; median/maximum lifespan:
2 RU486: 77/90, + RU486 77/83). CHP analysis showed that the response to RU486 in S1106.PntP1 was significantly different from the response in
S1106.Pnt
P1 dfoxo (p,10215) but not in S1106.Pnt
P1 dfoxo AopACT (p = 0.5) females. C Survival of TIGS.dfoxo female flies in the presence or absence
of RU486. Log-rank test detected no significant differences (p = 0.3; total dead/censored: 2 RU486 152/1, + RU486 149/2; median/maximum lifespan:
2 RU486: 77/87, + RU486 77/86). D Survival of female flies expressing dfoxo, PntP1 and AopACT under the control of TIGS in the presence or absence or
RU486. Log-rank test revealed significant effect of RU486 for TIGS.PntP1 (p,1024; total dead/censored: 2 RU486 140/2, + RU486 136/7; median/
maximum lifespan: 2 RU486: 74/86, + RU486 35/50), TIGS.PntP1 dfoxo (p,1024; total dead/censored: 2 RU486 146/3, + RU486 148/1; median/
maximum lifespan: 2 RU486: 74/85, + RU486 32/45) and TIGS.PntP1 dfoxo AopACT (p = 0.1; total dead/censored: 2 RU486 143/1, + RU486 155/1;
median/maximum lifespan: 2 RU486: 72/85, + RU486 35/55). CHP analysis showed that the response to RU486 in TIGS.PntP1 was significantly
different from the response in TIGS.PntP1 dfoxo (p = 261024) but not in TIGS.PntP1 dfoxo AopACT (p = 0.8) females.
doi:10.1371/journal.pgen.1004619.g004
dFOXO-AOP-PNT Transcriptional Circuit in Lifespan
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contribution of the gut to S1106-triggered phenotypes [54]. The
gut is a highly regionalised organ with several cell types [55,56]
and we confirmed that the two drivers activate transgene
expression in similar regions (Figure S3A), both driving
expression in the enterocytes (Figure S3B). Feeding RU486 to
TIGS.dfoxo females had no significant effect on lifespan
(Figure 4C), even though dfoxo was induced in the gut (Figure
S1A) and activated the expression of Aop (Figure 3C). With the
caveat that the levels of expression achieved with TIGS and S1106
in the gut are not identical (Figure S1A, S3A) and the two drivers
may not drive in completely overlapping subsets of gut cells
(Figure S3A and B), our data indicate that activation of dFOXO
in the gut alone is insufficient for lifespan extension.
On the other hand, the induction of PntP1 solely in the adult gut
was highly detrimental for the fly (Figure 4D), while RU486 had
no effect on the lifespan of the TIGS-alone or UAS-PntP1-alone
controls (Figure S3C and D). The interaction between dfoxo and
Pnt revealed with the TIGS driver was similar to that observed
with S1106: induction of dfoxo exacerbated the toxicity of Pnt
P1
and this, in turn, could be remedied by further induction of
AopACT (Figure 4D). While the magnitude of this synergistic
effect was smaller with TIGS than S1106, CHP analysis confirmed
that the response to RU486 in TIGS.PntP1 females was
significantly different from that in TIGS.PntP1 dfoxo (p,1024),
but not in TIGS.PntP1 dfoxo AopACT females (p = 0.8). Hence,
the dFOXO-PNT-AOP interaction can be mapped specifically to
the gut. Note, however, that we cannot exclude the possibility of a
similar interaction also occurring in the fat body.
Overall, our data are consistent with dFOXO up-regulating
Aop transcription in the gut in order to counteract the activity of
PNT. In this way, dFOXO prevents the detrimental effect that
would result from dFOXO being active at the same time as PNT
in that organ.
dFOXO and AOP share binding locations
Intuitively, the genetic interactions observed between dfoxo and
Aop/Pnt were not consistent with a simple, linear cascade of
dFOXO acting on AOP/PNT to influence lifespan (Figure 5A).
To formally examine this, we used Boolean network modelling.
We created network configurations with dFOXO, AOP, PNT and
‘‘lifespan’’ as nodes that can take values of 0 or 1 (inactive/short
life or active/long life) and described the relationships between
them using Boolean logic operators. We then perturbed the
network by fixing either dFOXO or PNT or both as ‘‘active’’ and
examined the probability that lifespan will take on the value of 1
(long life) after 1000 state transition using Markov chain
simulations. This type of modelling formalised what was intuitively
evident: the synergistic negative effect of dfoxo and Pnt co-
activation could be recapitulated by a network circuit that includes
a feed-forward loop between dfoxo and Pnt with a negative effect
on lifespan (described by a NAND operator), but not by a linear
cascade (Figure 5A).
Feed-forward loops involve co-regulation of the same targets,
and are often accompanied by extensive overlaps in genomic sites
bound by the TFs [57]. To gather further evidence for the
existence of this feed-forward loop, we determined the relationship
between the sites bound by the AOP/PNT couple and dFOXO.
We performed ChIP-chip on flies expressing FLAG-AOPACT,
since both PNT and AOP are known to bind the same sequences,
competing for the same sites [51–53].
To facilitate the comparisons with dFOXO, we used the S1106
driver and the RU486 inducer, with the control IP performed with an
anti-FLAG antibody on chromatin from flies expressing untagged
AOPACT (ArrayExpress accession number: E-MTAB-1306). We
discovered ,4000 genomic regions bound by FLAG-AOPACT
neighbouring some 3000 genes, including the dfoxo locus, with
good correlation between biological repeats (Figure S4A). An
example of peaks is given in Figure 5B. The binding locations
were associated with genes and tended to occur in the 59 region
(Figure S4B), consistent with a role in promoter-proximal
regulation of transcription. Similarly to the recently published
AOP binding locations observed in larvae [58], we found that
AOP tended to bind long stretches of DNA, longer than
dFOXO (Figure S4C). At the same time, over 80% of the
regions bound in adult gut/fat body were distinct from those
bound in larvae (Figure S4D).
We found a significant and substantial overlap in the genes
bound by GFP-dFOXO and those bound by FLAG-AOPACT
(p,1025, Figure 5C), indicating that AOP/PNT and dFOXO
may regulate numerous genes in common. Furthermore, dFOXO
did not just bind in the vicinity of the same genes but actually to
the same regions of the DNA: 60% of GFP-dFOXO-bound
regions directly overlapped regions of FLAG-AOPACT binding
(Figure 5D). This striking and significant (p,1023) overlap in
sites bound corroborates the existence of a feed-forward loop
between AOP/PNT and dFOXO. Furthermore, the genetic
interactions we observed between dfoxo and Pnt/Aop are likely to
be mediated by functional interactions on the shared regulatory
regions.
Pnt and dfoxo synergistically affect lipid metabolism
The strength of the negative synergistic effect observed between
dfoxo and Pnt prompted us to seek out its physiological basis. To
initiate this investigation, we looked at the GO categories that are
over-represented in genes bound by FLAG-AOPACT. The most
over-represented functional category was ‘‘lipid particle’’
(p = 3610217, Figure 6A), a GO category that includes lipid
droplets, sites of cellular lipid storage. This was also the most over-
represented category in the set of genes bound by both FLAG-
AOPACT and GFP-dFOXO (p= 361025, Figure 6A), indicating
that PNT/AOP and dFOXO together regulate lipid metabolism.
Activation of dFOXO in the aging gut represses two gastric
lipases, encoded by lipA (a.k.a. magro) and CG6295 genes [39].
These two lipases are thought to facilitate assimilation of ingested
lipids, and their repression by dFOXO results in a decrease in lipid
stores and a shortened lifespan [39]. We observed the detrimental
effects of dFOXO activation in the gut to be dependent on
simultaneous activation of PNT (Figure 4B, C and D),
prompting us to examine whether the expression of either lipA
or CG6295 was synergistically regulated by dfoxo and Pnt. We
used the S1106 driver, where the synergistic effect on lifespan is
pronounced, and found that both dfoxo and PntP1 resulted in
repression of CG6295, 3-fold and 8-fold, respectively (Fig-
ure 6B). When the two TF were co-expressed, the reduction in
CG6295 was even greater, reaching 80-fold reduction after only 5
days of transgene induction (Figure 6B). Indeed, a linear model
revealed a significant difference in the way the three genotypes
responded to RU486 (p,1024), and the amount of CG6295
transcript was significantly different between S1106.Pnt
P1 +
RU486 or S1106.dfoxo + RU486 and S1106.PntP1 dfoxo +
RU486 conditions (p,1024). Hence dfoxo and Pnt synergistically
repress the CG6295 lipase. The effect of the two TFs on lipA was
similar but smaller, and there was no significant difference
between S1106.dfoxo + RU486 and S1106.PntP1 dfoxo +
RU486 conditions (p.0.05, Figure S5A). Note that neither
AOPACT nor dFOXO bind in the vicinity of CG6295 and hence
the effects on the expression of this gene are likely to involve an
intermediate factor.
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To examine whether the synergistic effect on the expression of
the CG6295 lipase had a significant physiological consequence, we
determined the levels of triacylglycerol (TAG) stores in flies
expressing dfoxo, Pnt or both, under the control of the S1106
driver. We found that the levels of TAG paralleled the levels of
CG6295 transcript (Figure 6C) and, using a linear model, we
confirmed that the effects of RU486 on the TAG levels in the 3
genotypes were significantly different (p = 0.01), with the TAG
being significantly more depleted in S1106.PntP1 dfoxo flies
than in the other two genotypes after only 5 days of RU486
feeding (p,0.02, Figure 6C).
The effect on CG6295 expression and TAG levels could be
symptomatic of a more general loss of gut integrity. The function
of the gut as a barrier is a good surrogate for overall gut integrity
and is important for survival [59]. The effectiveness of this barrier
can be assessed by feeding flies a food containing a dye
(fluoresceine) and scoring the number of flies in which the gut is
unable to exclude this dye from the whole body (‘‘smurf’’
phenotype) [59]. We found that driving dfoxo and PntP1 for 3
weeks using S1106 did not increase the proportion of smurfs in the
population (Figure S5B), while the effect on lipid metabolism was
evident after only 5 days (Figure 6C). This confirmed that the
effect on lipid metabolism was not due to a general loss of gut
integrity. In addition, we also observed no significant changes in
feeding behaviour of S1106.Pnt
P1 dfoxo females after RU486
treatment, as assessed with the proboscis-extension assay (Figure
S5C).
Based on these data, we propose that the detrimental synergy
between dfoxo and Pnt arises from a mis-regulation of lipid
metabolism resulting in a profound drop in TAG stores. Indeed,
Figure 5. dFOXO and AOPACT share binding sites across the genome. A Boolean network models of dFOXO-AOP-PNT-lifespan interaction.
The linear model is indicated in grey and the feedforward model in red. The logic gate symbols for AND, NOT and NAND (NOT AND) are used, and in
the case shown NAND means that only the combined effect of dFOXO and PNT is detrimental to lifespan. For each model the probability of a positive
outcome for lifespan (lifespan= 1; y axis) after 1000 state transition was determined using Markov chain simulations after fixing either dFOXO or PNT
or both as active ( = 1; x axis). Only the feedforward model can capture the synergistic negative effects of the two TFs. B ChIP-chip traces, showing the
enrichment (log2-transformed) of the FLAG-AOP
ACT-immunoprecipitated DNA over total chromatin, are averages of three biological repeats after
subtraction of the mock control and are shown over a region of chromosome 3R. Red denotes the enrichment associated with peak regions. C
Proportional Venn diagram showing the overlap between the genes in the vicinity (,1 kb) of GFP-dFOXO or FLAG-AOPACT binding in the gut/fat
body (Hypergeometric test, p,1025). D Proportional Venn diagram showing the overlap in GFP-dFOXO-bound and FLAG-AOPACT-bound genomic
sites. Note that the average overlap is shown, since one peak in one set can overlap multiple peaks in the other due to differing peak lengths: 819
GFP-dFOXO-bound and 810 FLAG-AOPACT-bound sites are in the overlap. Bootstrap analysis revealed the overlap as significant (p,1023).
doi:10.1371/journal.pgen.1004619.g005
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S1106.PntP1 dfoxo flies were starvation sensitive after 5 days of
RU486 feeding, and this sensitivity could be reversed by co-
induction of AopACT (Figure S5D).
Activation of AOP alone can extend lifespan
We next focused on other possible roles of Aop in Drosophila
lifespan. Expression of the activated form of Aop in the flies
co-expressing dfoxo and PntP1 with S1106 driver had a
substantially beneficial effect on lifespan (Figure 4B). This was
due, in part, to its role in preventing dFOXO and PNT co-
activation, but we hypothesised that activation of AOP might
additionally increase the lifespan of wild type flies. We induced
expression of the activated form of AOP (AopACT) using the S1106
driver and the RU486 inducer in an otherwise wild-type adult
female. This resulted in significant lifespan-extension
(p = 2610210), increasing the median by 14% and maximal
lifespan by 11% (Figure 7A), while RU486 feeding had no effect
on the lifespans of the driver- or transgene-alone controls (Figure
S6A and B). This effect was robust and observed in six
independent experiments, performed in the course of three years,
with average median lifespan extension of 12% (Figure 7B).
Furthermore, independently generated, FLAG-tagged AopACT
also extended lifespan (Figure S6C).
To examine whether this lifespan-extending effect could be
localised to the same tissues where the interaction between dfoxo
and Pnt/Aop occurs, we drove AopACT with the gut specific TIGS
driver. Induction of AopACT using the TIGS driver did not extend
lifespan (Figure 7B), despite transgene induction in the gut with
both TIGS and S1106 drivers (Figure S6D). Although the
induction levels were lower with TIGS (Figure S6D), they must
still be physiologically relevant because, even with this driver,
AopACT could partially remedy the toxicity of Pnt and dfoxo co-
activation (Figure 4D).
Our data are consistent with two roles of Aop in lifespan
modulation: (1) Aop can counteract the negative effect of dfoxo and
Pnt co-activation in the gut, (2) its additional activation in the fat
body extends wild-type lifespan. The lifespan extension by AopACT
in flies co-expressing dfoxo and PntP1 under S1106 control most
likely combines the two beneficial effects of Aop activation, since
the effect appears greater in that context than in the otherwise
wild-type female (median increased by 22% between S1106.
dfoxo PntP1 + RU486 and S1106.dfoxo PntP1 AopACT + RU486,
Figure 4B, versus 12% average extension in wild-type, Fig-
ure 7B).
We examined other phenotypes triggered in S1106.Aop
ACT
females by RU486 feeding, focusing on phenotypes often
associated with lifespan extension. RU486 feeding did not cause
any significant changes in starvation, hydrogen peroxide or DDT
resistance; any changes to whole body trehalose, glycogen or lipid
content; feeding or fecundity (Figure S7). However, we did find
that induction of AopACT in the adult gut and fat body resulted in
increased circulating sugars (Figure 7C), a diabetic phenotype
potentially indicative of slightly reduced IIS. Pnt is known to
promote IIS in larvae and its gain-of-function stimulates clearance
of circulating sugars [60], consistent with the converse phenotype
we observed in S1106.Aop
ACT adults.
Since FoxOs are inhibited by IIS [61], Aop could act to reduce
IIS and activate dFOXO, thereby increasing the lifespan of
otherwise wild-type females. However, AopACT extended lifespan
in complete absence of dfoxo (Figure 7D), and CPH analysis
found no evidence for a difference in the response to RU486 in
dfoxoD/D S1106.Aop
ACT versus S1106.Aop
ACT females
(p = 0.2). Hence, Aop extends wild-type lifespan independently of
dfoxo.
dFOXO and AOP share targets in the fat body
We further examined the function of Aop in the fat body, where
its activity appears important for lifespan but where it is not
regulated by dfoxo. We found that AOP transcript and protein
levels were strongly induced in the fat body when S1106.Aop
ACT
females were fed RU486 (Figure S8A), but in only a portion
Figure 6. dfoxo and Pnt act synergistically on lipid metabolism.
A Top three most significantly enriched GO categories within genes
bound by FLAG-AOPACT alone or FLAG-AOPACT and dFOXO, as
determined by EASE analysis. The intensity of red indicates log-10
derived p value associated with the enrichment. The complete GO
analysis is given in Dataset S1. B CG6296mRNA was quantified relative
to Act by qPCR in the females of the indicated genotypes, induced or
not with RU486. Boxplots show log-10 derived relative expression with
2 RU486 values set to zero. Data were analysed with a linear model and
the effects of RU486, genotype and their interaction were significant
(n = 4, p,1024), with S1106.dfoxo Pnt
P1 + RU486 condition being
different to all others (t-test , p,1024). C The levels of TAG were
quantified under the same conditions as in B. Data were analysed with a
linear model and the effects of RU486 (p = 261024), genotype (p,1024)
and their interaction (p = 0.01) were significant (n = 8, where 10
measurements were made and the lowest and highest measurement
removed from each group). The S1106.dfoxo Pnt
P1 + RU486 condition
was different from all others (t-test , p,0.05). The genotypes are
denoted with the same colours in B and C, with the legend given in B.
doi:10.1371/journal.pgen.1004619.g006
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(,2666%) of the fat body cells, suggesting heterogeneity of the
tissue (Figure 8A, for quantification see Figure S8B). This
mosaic expression was not due to the driver, because S1106 drove
GFP expression in all the cells of the tissue (Figure S8C).
To elucidate the function of Aop in the fat body we used
microarray analysis on dissected tissue to identify changes in gene
expression upon RU486 feeding in S1106.Aop
ACT females
(ArrayExpress accession number: E-MTAB-927). The induction
of AOPACT in only a few cells of the fat body precluded
identification of many genes with significant changes upon RU486
feeding. We identified 8 genes (p value cut off of 0.00017,
corresponding to 20% FDR, Figure 8B). Two of these were also
regulated by dfoxo (Figure 8B), and this modest overlap was
statistically significant (p = 261023). The functions regulated by
the two factors, as determined by Catmap analysis (Figure S9A)
were also partially overlapping. For example, both dfoxo and
AopACT had a negative effect on respiratory electron transport
chain (p= 10221 and p=761029 respectively), while AopACT
alone had an effect on carbohydrate metabolism (p = 9610218 for
AopACT, p.0.05 for dfoxo) (Figure S9A). Interestingly, we found
that the lifespan benefits from the induction of AopACT, dfoxo or
both were not significantly different (Figure S9B). This indicated
that the effects of the two factors are not additive and, in turn, that
the two are likely to affect lifespan via the same or related
physiological processes, in an otherwise wild-type background.
Interestingly, the most strongly up-regulated gene in the fat
body upon AopACT induction was also up-regulated by dFOXO in
the same tissue, albeit less strongly (Figure 8B). These observa-
tions were confirmed by qPCR (Figure 8C). This gene encodes a
signal peptide followed by an odorant binding protein (Obp)
domain - Obp99b. Non-sensory Obps are thought to bind and
carry lipophilic compounds, fulfilling similar functions to the
mammalian lipocalin family proteins, rather than acting in odour
perception [62,63]. Obp99b could represent a humoral factor,
induced by both dfoxo and Aop, mediating inter-tissue commu-
nication. Such inter-tissue communication is known to be
important in the physiological effects of tissue-restricted dfoxo
induction [4]. To establish that this Obp was actually secreted in
Figure 7. Aop extends lifespan. A Survival of S1106.Aop
ACT female flies in the presence or absence or RU486. Log-rank test detected significant
differences (p = 2610210; total dead/censored: 2 RU486 145/1, + RU486 129/3; median/maximum lifespan: 2 RU486: 74/87, + RU486 84/97). B
Median lifespan extension achieved by RU486 feeding in S1106.Aop
ACT (6 experiments) or TIGS.AopACT (3 experiments) females. Log-rank test
detected significant extension (p,0.05) of lifespan in 6 out of 6 S1106.Aop
ACT and in 1 out of 3 TIGS.AopACT trials. In one TIGS.AopACT trial lifespan
was shortened. C Haemolymph glucose and trehalose in S1106.Aop
ACT females fed or not RU486, where RU486 had a significant effect in each case
(t-test, p = 0.01 and 0.02 respectively; n = 8 where 10 measurements were made and the highest and lowest measurement removed from each group).
D Survival of S1106.Aop
ACT or dfoxoD/D S1106.Aop
ACT female flies in the presence or absence or RU486. Log-rank test detected significant
differences for both: S1106.Aop
ACT (p,1024; total dead/censored: 2 RU486 139/3, + RU486 136/7; median/maximum lifespan: 2 RU486: 77/87, +
RU486 86/94) and dfoxoD/D S1106.Aop
ACT (p,1024; total dead/censored: 2 RU486 138/0, + RU486 136/4; median/maximum lifespan: 2 RU486: 56/
81, + RU486 72/90). CHP analysis revealed significant effects of RU486 (p,10215) and dfoxo (p,10215) but no significant difference in the response to
RU486 between the two lines (p = 0.2).
doi:10.1371/journal.pgen.1004619.g007
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vivo we expressed a transgene encoding a V5-tagged Obp99b with
the S1106 driver. Feeding RU486 to these flies confirmed the
predicted enrichment of Obp99b-V5 in the haemolymph (Fig-
ure 8D) and revealed that its transcriptional up-regulation is
enough to release it in circulation. Hence, in the fat body, AopACT
and dfoxo regulate a common humoral factor, whose function
warrants further investigation.
Discussion
Our study clearly demonstrates the in-vivo complexity of
interactions that occur between FoxOs and the TFs they regulate.
It emphasises the need to untangle the tissue-specific transcrip-
tional networks within which FoxOs act in order to understand the
role of FoxO factors in lifespan.
We show that dFOXO activates the transcription of an ETS
repressor, Aop, in adult Drosophila gut to antagonise an ETS
activator, Pnt, and avert the detrimental effects of the
co-activation of dFOXO and PNT. This interaction most likely
takes place at the gene promoters/enhances where AOP may
directly displace PNT from a dFOXO bound region. Whether this
interaction is facilitated by a direct protein-protein interaction
between dFOXO and AOP, or by juxtaposition of dFOXO and
AOP binding sites, remains to be determined.
Others have shown that induction of dfoxo solely in the gut is
detrimental for lifespan [39]. In our outbred, wild-caught
background, this detrimental effect is conditional on co-activation
of Pnt. Despite these differences, the deleterious physiological
outcome is likely to be based on mis-regulation of lipid metabolism
genes and a drop in TAG stores in both cases. In parallel, the
activation of AOP in the gut/fat body of otherwise wild-type
females has only two phenotypes: increase in lifespan and increase
in circulating sugars. The increase in circulating sugars is a
metabolic phenotype, generally not detrimental to fly lifespan as it
can be observed in a number of long-lived IIS mutants [64,65].
Figure 8. Aop and dfoxo both regulate a humoral factor, Obp99b, in the fat body. A AOP was visualised by immunofuorescence in fat
bodies of S1106.Aop
ACT flies induced or not with RU486. In the merged image, AOP is shown in green, DAPI-stained nuclei in blue. AOP accumulates
in nuclei of 2666% of fat body cells. B Genes regulated by RU486 induction in fat bodies of S1106.Aop
ACT flies were determined by microarray
analysis and compared to changes in the fat body upon induction of S1106.dfoxo. Mean log2 fold change caused by induction of Aop
ACT (y-axis) is
plotted against that caused by induction of dfoxo (x-axis). Genes with significant differential expression (at 20% FDR) upon induction of AopACT are
shown in red, dfoxo in green and both AopACT and dfoxo in blue. The location of the Obp99b gene on the graph is indicated. C The levels of Obp99b
mRNA in abdominal fat body mRNAs were determined relative to actin by qPCR upon RU486 induction in S1106.Aop
ACT (n = 4) or S1106.dfoxo
(n = 8) female flies. Boxplots show log-10 derived ratios scaled to set the 2RU486 condition to 0. Data were analysed using a mixed-effects linear
model with genotype and RU486 as main effects and dissection batch as a random effect. Both main effects as well as their interaction were
significant (p,0.01), and one-tailed t-test indicated the +RU486 condition had more Obp99b transcript for each genotype (p,0.05). D Obp99b-V5
was detected in haemolymph (1 ml) of S1106.Obp99b-V5 female flies, fed or not RU486, or in whole-fly extracts (equivalent of half a fly) using anti-V5
antibody. The secreted IMP-L2 protein was used as a loading control.
doi:10.1371/journal.pgen.1004619.g008
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Together with the effects observed upon dfoxo/Pnt co-activation,
it indicates that the Aop/Pnt couple have metabolic functions in
the adult fly.
FoxOs are regulated by AKT [61], while ETS factors, such as
AOP and PNT, are regulated by ERK [51]. In turn, both ERK
and AKT are activated in response to activation of receptor
tyrosine kinases (RTK) [66]. Viewed in this context, the
interaction between dFOXO, inhibited by AKT, and AOP,
inhibited by ERK, insures that the two branches down-stream of
RTKs are coordinated. Our findings reveal the mis-coordination
of the two branches to be highly detrimental, with the cross-talk
between dfoxo and Aop set up to prevent it. This mechanism for
coordination of the activities of the two branches, via interactions
between FoxO and ETS factors, is potentially relevant in
numerous contexts beyond Drosophila lifespan.
Dissecting the relationship between dFOXO and AOP led us to
the discovery of a second beneficial role for AOP and the
identification of Aop as a longevity determinant in its own right.
Aop has an important and well-established role in Drosophila
development. The gene was initially isolated as encoding a
negative regulator of neural development, in the context of the
Drosphila eye [47]. Subsequent studies revealed it to be a general
inhibitor of differentiation [48,67]. Its role in the adult has not
been investigated and its effect on lifespan was completely
unsuspected.
Several contingent observations lead us to speculate that the
role of Aop as a fly longevity gene, as well as its interaction with
dfoxo, will be conserved in its mammal orthologue Etv6: Aop and
Etv6 display clear conservation of function in other physiological
processes [45]; the common roles of dfoxo and Aop in fly lifespan
are paralleled by shared roles of FoxO factors and Etv6 in
mammals [30,46]; the neuroendocrine axes controlling growth are
important in mammalian lifespan [68] and Etv6 has been
identified as associated with human height in genome-wide
association studies [69,70].
Materials and Methods
Fly lines, husbandry, lifespan and physiological assays
S1106 [1,31], TIGS [31] UAS-dfoxo [1], UAS-GFP-dfoxo [32],
UAS-AopACT [48], UAS-Obp99b-V5.5 [71], UAS-PntP1 [51],
dfoxoD94 [6] and UAS-GFPRNAi [72] were backcrossed at least 6
times into the wild-type, outbred, Dahomey population carrying
the w1118 mutation, which had been cured of Wolbachia infection
over five years ago, and frequently outcrossed back into the same
wild-type population. The UAS-AopRNAi construct was obtained
from the TRiP collection (HMS01256) [49], and was tracked by
PCR during backcrosses as above. The Dahomey stock was
collected in 1970 in Dahomey (now Benin) and has been kept in
population cages maintaining its lifespan and fecundity at levels
similar to freshly caught stocks. Combinations of transgenes/
mutants were created using standard fly genetic techniques while
avoiding population bottlenecks. To create UAS-FLAG-AopACT,
the AopACT open reading frame was amplified from genomic DNA
of flies carrying UAS-AopACT (primers are given in Protocol S1)
and cloned into pENTR-D-TOPO vector, confirmed by sequenc-
ing and transferred to pTFW P-element-based vector, integrated
into the fly genome and the transgene backcrossed as above.
The lines were maintained, and all experiments performed, at
25uC with 60% humidity and 12 h:12 h light:dark cycle, on sugar-
yeast-agar (1SYA) food [73]. Experimental flies developed at
standardised densities and once-mated females we sorted on day
two of adulthood onto food containing 200 mM RU486 (Sigma) or
control food as required. Lifespans were performed as described
[1]. Heamolymph extraction and measurements of circulating
glucose and trahalose, and other phenotyping, were performed as
described [4,74,75]. Examination of the ‘‘smurf’’ phenotype was
carried out using fluorescein in 1SYA +/2 RU486 as described
[59], except the flies were kept on the food for 18 h.
Chromatin immunoprecipitation
Biological triplicates were done for all fly chromatin prepara-
tions. For each experiment all the batching was done so that the
treatments to be compared were carried out in parallel.
Chromatin was prepared from 7-day old S1106.GFP-dfoxo or
S1106.FLAG-Aop
ACT (experimental) or S1106.dfoxo or
S1106.Aop
ACT (mock control) females fed RU486-containing
food from day two of adulthood, as follows: 1000 females were
crushed to a fine powder under liquid nitrogen and re-suspended
in 6 ml of PBS supplemented with Protease Inhibitors Cocktail
(10 ml per ml, Sigma). Cross-linking was performed with 0.5%
formaldehyde for 10 min and quenched with addition of 1.5 ml of
2.5 M glycine. The cross-linked chromatin was recovered by
centrifugation and washed twice with FA/SDS buffer (50 mM
Hepes-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% Na
deoxycholate, 0.1% SDS, 1% Triton –X-100 and 1 mM PMSF)
re-suspended in the same and incubated for 1 h at 4uC.
Chromatin was again recovered by centrifugation and sheared
to an average size of 400 bp by sonication, giving on average 6 ml
of chromatin in FA/SDS.
For anti-GFP IPs, anti-GFP antibody (Abcam, 1 ml per IP) was
bound to Protein-G Dynabeads (Invitrogen) and incubated for 2 h
at room temperature with 450 ml of chromatin. Beads were
washed once with FA/SDS, 3 times with FA/SDS containing
500 mM NaCl, once with 10 mM Tris-HCl pH 8, 250 mM LiCl,
1 mM EDTA, 1% NP40 and 0.5% Na deoxycholate, and once
with TE. For array hybridisation, the entire IP after volume
reduction, or 50 ng of total chromatin DNA, were amplified two
times (Whole Genome Amplification kit, Sigma) as per manufac-
turer’s instructions. The material from the IP was hybridised
against the input material. The labelling and hybridisations were
carried out by Nimblegen Systems, using custom Drosophila
whole-genome tiling arrays with probes spaced approximately
every 300 bp, as described [76]. ChIP-chip data were normalized
using the LIMMA package [77] in Bioconductor [78], applying
loess normalization within each array and quantile normalization
between arrays. Replicate information was pooled by taking the
median probe value for each set of arrays and was smoothed along
each chromosome using a running median within a window of
three probes. Experimental signal was adjusted by mock control
(pre-immune serum) data by direct subtraction of median probe
intensity values. Peaks were called using the Ringo package [79] in
R, using a y0 threshold of 0.97 and a distance cut-off of 600 bp.
Anti-FLAG IPs were performed essentially as above, except
anti-FLAG antibody (Sigma, 3 ml per IP) was used on 1350 ml of
chromatin. Subsequent processing was the same except that
100 mM dUTP was spiked in during amplification, and chromatin
and IP were separately hybridized to Affymetrix Drosophila Tiling
2.0R arrays. The IP to chromatin ratios were computationally
determined after normalisation using the Starr package [80], and
peaks identified as above, except that smoothing was over 5
probes.
Genes were associated to peaks if any gene feature occurred
within 1 kb upstream or downstream of the outermost peak
probes. The overlap between regions bound by GFP-dFOXO and
FLAG-AOPACT was compared to the random distribution by
bootstrap analysis (10000 iterations looking for marginal basepair
dFOXO-AOP-PNT Transcriptional Circuit in Lifespan
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overlap in block bootstrap) [81] and the Z-score and p value
calculated.
Chromatin was also prepared from wild-type female flies and
serum-starved S2 cells and IP performed with the affinity-purified
anti-dFOXO antibody [32] as described [17]. Primers used for
qPCR are given in Protocol S1.
Microarray and mRNA expression analysis
For microarray analysis of dfoxo regulated genes at least four
and up to five biological repeats of 7-day old S1106 or S1106.
dfoxo females that had been fed RU486-containing or control
food, were dissected removing either the mid-gut (50 per sample),
or the abdominal/thorasic fat body (25 per sample) as associated
with the cuticle, and the RNA extracted with RNeasy (Qiagen).
The fat body dissections were performed by isolating and opening
the fly thorax and/or abdomen, removing the internal organs with
minimal disturbance of the fat body and keeping the fat body
associated with the cuticle. We estimate that such dissection of the
fat body results in ,80% purity. For microarray analysis of
AopACT regulated genes four biological repeats of 7-day old
S1106.Aop
ACT females that had been fed RU486-containing or
control food, were dissected removing the abdominal fat body (25
per sample) as associated with the cuticle and the RNA extracted
with RNeasy (Qiagen). All dissections and subsequent processing
were done in batches so that the samples to be compared were
always processed in parallel. The RNA was further processed into
cRNA using standard Affymetrix protocols and hybridized to the
Affymetrix Drosophila Genome 2.0 Genechip at SHWFGF/
Glasgow Polyomics (University of Glasgow). The data were
analysed in R. They were summarised and normalised using
RMA as implemented in the LIMMA package [82–84]. Differ-
ential expression was assessed using linear models and the
empirical Bayes moderated t-statistic implemented in LIMMA.
For dfoxo-regulated gene analysis the effects in the linear model
were: ‘‘dissection batch’’, ‘‘S1106+RU486’’, ‘‘S1106.dfoxo’’ and
‘‘S1106.dfoxo+RU486’’; for AopACT-regulated genes: ‘‘dissection
batch’’ and ‘‘S1106.Aop
ACT+RU486’’. Present/Absent calls were
performed with Mas5 and transcripts present on at least four
arrays for fat body, or at least five for gut were kept for further
analysis. FDR was controlled using the described procedure [85].
For Gene Ontology enrichment, Catmap [40], or DAVID EASE
[86] analyses were performed.
For qPCR analysis RNA was isolated from five to 10 midguts,
five fat bodies or five guts and fat bodies with TRIZOL, converted
into cDNA and qPCR performed as described [17]. The primers
are given in Protocol S1.
Boolean network modeling
The network was modelled using BoolNet in R [87].
Immunofluorescence and western blots
Abdominal fat bodies as associated with the cuticle were
dissected and immunofluorescence was performed using a
monoclonal mouse anti-AOP antibody [48] at 1:100 dilution
using the described protocol [74]. For GFP detection, dissected
body parts were fixed for 10 min before visualisation. Images were
captured on Zeiss LSM 700, and quantified using ImageJ. For
western blots, proteins were extracted from whole flies, or from 10
fat bodies, with TCA, or obtained by denaturing adult
haemplymph in Lemmini buffer [74], separated by SDS-PAGE,
transferred to nitrocellulose and probed with anti-V5 antibody
(1:500, Sigma), anti-IMP-L2 (1:2500) [74], anti-ACTIN (1:1000,
Abcam) or anti-AOP (1:500).
Statistical analysis
Statistical analyses were performed in JMP (version 9) software
(SAS Institute), R or Excel (Microsoft). qPCR data were log-
transformed to fit a normal distribution and analysed with
ANOVA, linear models or mixed effects linear models, followed
by selected pair-wise comparisons using t-test. Survival analysis
was performed with Log-rank, CPH or mixed-effects CPH
methods in JMP, or in R using survival and coxme pack-
ages (Terry Therneau, http://CRAN.R-project.org/package =
survival, http://CRAN.R-project.org/package = coxme). Analysis
of smurf data was performed with a generalised linear model in R
and quasibinomial distribution. Analysis of feeding was performed
in JMP, using a generalised linear model, binomial distribution
and over-dispersion adjustment. Significance of set overlaps was
determined with Hypergeometric distribution. Details of tests
performed are given in figure legends.
Array data
The unprocessed array data are available from ArrayExpress
under accession numbers: E-MTAB-1020, E-MTAB-1021, E-
MTAB-927, and E-MTAB-1306.
Supporting Information
Figure S1 A dfoxo mRNA was quantified relative to Act by
qPCR in the guts or fat bodies of S1106.dfoxo or TIGS.dfoxo
females, induced or not with RU486. Boxplots show log-10
derived relative expression with 2 RU486 values set to zero. Gut:
data were analysed with a linear model and the effect of genotype
was not significant (p = 0.08), while the effect of RU486 (p,1024)
and the interaction (p= 0.02) were significant. Each 2RU486 was
significantly different to its respective +RU486 condition, and the
two +RU486 conditions were also significantly different (t-test,
n = 3–6, p,0.05). Fat body: The 2RU486 and +RU486
conditions were significantly different (t-test, n = 3–5,
p = 861024) B Correlation of log-transformed, scaled, raw
intensity values (ratio of ChIP to input) for the three biological
repeats of anti-GFP ChIP-chip performed on chromatin from
S1106.GFP-dfoxo + RU486 (ChIP) or S1106.dfoxo + RU486
(mock) females for the probes within GFP-dFOXO bound peaks.
C The sites bound by GFP-dFOXO when induced by the S1106
driver in the gut and fat body were compared to the locations
bound by endogenous dFOXO in whole flies [17]. D The
distribution across genomic features of the GFP-dFOXO binding
in the gut and fat body was compared to the random distribution
determined from simulation of 1000 random peak sets, of identical
size, length and chromosomal distribution and the Z-scores
calculated. The frequency of occurrence of all the shown features
was significantly different from random (p,1023). Upstream and
downstream refer to 1 kb from an annotated gene. ‘‘Genes’’ refers
to regions containing annotated genes, as opposed to gene-free
regions. E Motifs identified by MEME from the sequences bound
by dFOXO in the gut and fat body (above: E value = 1.66102264,
below: E value = 9.761027) that were similar to other forkhead
motifs (e.g above: Foxl1 secondary p= 261023, below: Foxj1
primary p= 4.561027). F The relative expression levels of the 5
TFs directly regulated by dfoxo induction in the gut. The
expression levels are from the microarray experiment profiling
gut mRNAs in S1106.dfoxo females with and without RU486
and are scaled to the 2 RU486 control for each gene. G The
intron-containing dfoxo mRNA was quantified relative to Actin
mRNA in whole S1106.dfoxo flies in presence or absence of
RU486. t-test indicated significant difference between the two
dFOXO-AOP-PNT Transcriptional Circuit in Lifespan
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conditions (n = 4, p = 0.01). Note the mRNA expressed from the
transgene is intron-less.
(PDF)
Figure S2 A Aop mRNA was quantified relative to Actin mRNA
in guts and fat bodies (combined) of S1106.Aop
RNAi flies in
presence or absence of RU486. t-test indicated significant
difference between the two conditions (n = 4, p = 0.04). B Survival
of female flies expressing RNAi construct targeting GFP in
combination with dfoxo. Log-Rank test detected significant
differences in survival with or without RU486 for S1106.
GFPRNAi dfoxo but not S1106.GFPRNAi females (S1106.
GFPRNAi: p.0.05; total dead/censored: 2 RU486 117/1, +
RU486 114/1; median/maximum lifespan: 2 RU486: 73/85, +
RU486 76/87; S1106.GFPRNAi dfoxo: p,3610
23; total dead/
censored: 2 RU486 114/1, + RU486 136/5; median/maximum
lifespan: 2 RU486: 78/90, + RU486 87/97). CPH analysis
revealed no significant effect of RU486, significant effect of dfoxo
(p = 761024) and significant interaction (p = 561025). C Aop,
dfoxo and Pnt mRNA was quantified relative to Actin mRNA in
S1106.PntP1 dfoxo and S1106.PntP1 dfoxo Aop
ACT females in
presence or absence of RU486. Boxplots show log-10 derived
relative expression with 2 RU486 values set to zero. Data (n = 4)
for each transcript were analysed with a linear model. Aop: There
was a significant effect of genotype (p= 0.003) and significant effect
of RU486 by genotype interaction (p = 0.003), where the levels in
S1106.PntP1 dfoxo Aop
ACT + RU486 were significantly different
to all others (p,0.05). dfoxo: Only the effect of RU484 was
significant (p = 0.003). Pnt: Only the effect of RU486 was
significant (p,1024). Hence, the induction of dfoxo and Pnt is
not different between the genotypes.
(PDF)
Figure S3 A GFP expression was visualised in midguts of
S1106.GFP and TIGS.GFP females. Red squares denote the
anterior and the mid regions of the midgut were both drivers
activate transgene expression. The settings used to capture images
for the two drivers are the same and the GFP intensities between
the two drivers can be compared. B Parts of the anterior midgut
showing GFP expression in individual cells observed in S1106.
GFP and TIGS.GFP females. Both drivers express in the
enterocytes, which can be recognised by the intense DAPI staining
and large nuclei. Note the settings used to capture the images for
S1106.GFP and TIGS.GFP females were not the same so that
the intensity of GFP cannot be compared between drivers. C
Survival of female flies carrying TIGS alone in the presence or
absence of RU486. Log-rank detected no significant differences
(p.0.05, n<130). D Survival of female flies carrying UAS-PntP1
alone in the presence or absence of RU486. Log-rank detected no
significant differences (p.0.05, n<140).
(PDF)
Figure S4 A Correlation of log-transformed ratios (ChIP to
input) of scaled, raw intensity values for the three biological repeats
of anti-FLAG ChIP-chip performed on chromatin from S1106.
FLAG-AopACT + RU486 (ChIP) or S1106.AopACT + RU486
(mock) females for the probes within FLAG-AOPACT bound
peaks. B The distribution across genomic features of the FLAG-
AOPACT binding in the gut and fat body was compared to the
random distribution by bootstrap analysis [81] and the Z-scores
calculated. The frequency of occurrence of all the shown features
was significantly different from random (p,1023). Upstream and
downstream refer to 1 kb from an annotated gene. ‘‘Genes’’ refers
to regions containing annotated genes, as opposed to gene-free
regions. C The frequency of the lengths of regions bound by GFP-
dFOXO (green) or FLAG-AOPACT (red) was plotted as smoothed
density. D Percentage of regions bound by GFP-dFOXO or
FLAG-AOPACT in adult gut/fat body that overlap the regions
bound by AOP in larvae [58]. ‘‘66’’ and ‘‘stage 11’’ refer to top
3% of the peaks from two different experiments described by
Webber and colleagues [58].
(PDF)
Figure S5 A lipA mRNA was quantified relative to Act by qPCR
in the females of the indicated genotypes, induced or not with
RU486. Boxplots show log-10 derived relative expression with 2
RU486 values set to 0. Data were analysed with a linear model
and the effects of RU486, genotype and their interaction were
significant (n = 4, p,1023), however, the S1106.dfoxo Pnt
P1 +
RU486 condition was not significantly different from the S1106.
dfoxo + RU486 condition (t-test , p = 0.2). B The proportion of
‘‘smurfs’’ (flies with impaired gut barrier function, n= 80–95) in
the noted genotypes after 3 weeks of RU486 feeding, or the 2
RU486 condition. Data were analysed with a generalised linear
model and quasibinomial distribution, and no significant effect of
RU486, genotype or their interaction was detected (p.0.25). C
Proportion of S1106.dfoxo Pnt
P1 females feeding after 5 days of
feeding on RU486 or control food. Data were analysed with a
generalised linear model, binomial distribution adjusted for over-
dispersion, and no significant effect of RU486 was detected
(p = 0.1). D Starvation survival of S1106. Pnt
P1 dfoxo and
S1106. Pnt
P1 dfoxo AopACT females after 5 days of feeding on
RU486 or the control food. RU486 significantly reduced the
survival of S1106. Pnt
P1 dfoxo females (Log-rank, n,100,
p = 461024) but not of the S1106. Pnt
P1 dfoxo AopACT females
(Log-rank, n,100, p = 0.4). CHP analysis detected a significant
effect of RU486 (p = 961023), but marginal effect of genotype
(p = 0.06) and marginal RU486 by genotype interaction (p = 0.08).
(PDF)
Figure S6 A Survival of S1106-alone control females in the
absence or presence of RU486. Log-rank test detected no
significant differences (p.0.05, n<150). B Survival of UAS-
AopACT-alone control females in the absence or presence of
RU486. Log-rank test detected no significant differences (p.0.05,
n<150). C Lifespan of S1106.FLAG-AopACT female flies in
presence or absence of RU486. The two conditions were different
by Log-rank test (p = 361025; total dead/censored: 2 RU486
143/4, + RU486 147/0; median/maximum lifespan: 2 RU486:
71/83, + RU486 76/87). D Aop mRNA was quantified relative to
Act by qPCR in the guts of S1106.Aop
ACT or TIGS.AopACT
females, induced or not with RU486. Boxplots show log-10
derived relative expression with 2RU486 values set to zero. Data
(n = 2–4) were analysed with a linear model and the effects of
genotype, RU486 and their interaction were all significant(p,
1024). Each + RU486 was significantly different to its respective 2
RU486 condition, and the two + RU486 conditions were also
significantly different (t-test, p,0.05).
(PDF)
Figure S7 S1106.Aop
ACT female flies were placed on appro-
priate food on day two and either frozen on day 7 for metabolic
assays or kept for stress and fecundity assays. For stress assays, 7-
day old females were placed on food containing H2O2 (no yeast) or
DDT, or were starved on food containing agar alone, and the
number of dead flies scored over time. There were no significant
differences in survival by Long-rank test (n<100, p.0.05) in any
of the conditions. Levels of trahalose were determined as number
of moles of trehalose per fly weight, of lipids as weight of TAG per
fly weight, of glycogen as weight of glycogen per fly weight and all
are shown as percentage of no-RU486 control. There were no
significant differences by t-test (n = 10, p.0.05). Eggs laid per
dFOXO-AOP-PNT Transcriptional Circuit in Lifespan
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female per day (averaged per vial of 10 females) were determined
once per week for the first 4 weeks and summed to give an estimate
of lifetime fecundity. There were no significant differences (t-test,
n = 10, p.0.05). Feeding was assessed in 8-day old females and no
significant differences were detected.
(PDF)
Figure S8 A Aop mRNA (left) or AOP protein (right) levels were
determined against Act/ACT control by qPCR or western blots in
the fat bodies of S1106.Aop
ACT females fed RU486 or control
food. qPCR data were log-10 derived and significant difference
found between 2RU486 and + RU486 conditions (t-test,
p = 861024). B Quantification of the results presented in
Figure 8A. AOP was visualised by immunofuorescence in fat
bodies of S1106.Aop
ACT flies induced or not with RU486.
Intensity of nuclear AOP staining was quantified from confocal
images using Image J (intensity is presented on an arbitrary scale).
Average intensity from at least 3 cells from each animal was
calculated for each biological repeat, and location of the nucleus
was determined from DAPI staining. For + RU486 samples, the
nuclei were binned into ‘‘high’’ or ‘‘low’’ AOP stained ones by
visual inspection and quantified separately. Means 6 SEM are
shown. n= 3 animals2 RU486, n= 4 for + RU486; t-test detected
a significant difference (p,1024) between the ‘‘high AOP’’ nuclei
on + RU486 and nuclei on 2 RU486. The proportion of highly
stained nuclei was 26%+/26% in 4 animals fed RU486
examined. C S1106 drives expression in all the cells of the fat
body. S1106.GFP flies were fed or not RU486 from day two
until day 7 when GFP expression in the fat body was determined
by confocal microscopy. GFP was detected uniformly in all the
cells of the abdominal fat body.
(PDF)
Figure S9 A Biological process GO categories differentially
regulated (p,10210) in the fat body upon induction of dfoxo or
AopACT as determined by Catmap analysis. Any redundant
categories (overlap by more than 75%) were removed, retaining
the most specific category. The full list is given in Dataset S1.
The intensity of red shows the log10-transformed p-value
associated with differential regulation for each category. BMedian
lifespan extension caused by induction or dfoxo, AopACT or both
with RU486 and the S1106 driver in two independent
experimental trials. In each case RU486 had a significant, positive
effect on survival (Log-rank, p,1023). The survival data (n = 1664
deaths/23 censors) were analysed with a mixed effects CPH
model, with experimental trial as random effect, and the effect of
genotype (p,0.05) and RU486 (p = 10212) were significant but
their interaction was not (p.0.1), revealing that the two factors do
not have additive effects.
(PDF)
Dataset S1 Lists of genes and genomic locations and full Ease
and Catmap results mentioned in the manuscript.
(ZIP)
Protocol S1 Sequences of primers used in this study.
(PDF)
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